Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (5)
  • 2023 (7)
  • 2022 (12)
  • 2021 (16)
  • 2020 (4)
  • 2019 (1)

Subject

  • Drug Trafficking (103)
  • Prescription Drugs (75)
  • Diversion Division (37)
  • OCDETF/Task Force (34)
  • Fake Pills (29)
  • Synthetic drugs (25)
  • Guns/Weapons (24)
  • Seizures (Drugs/Property) (15)
  • Overdose (14)
  • Task Forces/Task Force Officers (12)
  • Arrests/Convictions - Major (11)
  • Guilty Plea (11)
  • Dark Web- Internet Trafficking (6)
  • Major Law Enforcement Operation (6)
  • Take Back Day (5)
  • Asset Forfeiture (3)
  • Gangs (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Outreach/Drug Prevention (2)
  • Press Conferences (2)
  • Public and Media Affairs - also see Congressional Affairs (2)
  • Congressional Affairs (1)
  • HIDTA (1)
  • Money Laundering (1)
  • Pharmaceuticals/Pharmacists/Physicians (47)

Drug Name

  • Opioids (45)
  • Fentanyl (26)
  • Hydromorphone (12)
  • Synthetic Opioids (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • Cocaine (2)
  • GHB (1)
  • Heroin (1)
  • Oxycodone (47)

Field Division

  • Washington, DC (11)
  • New York (8)
  • St. Louis (6)
  • Atlanta (5)
  • Miami (4)
  • Chicago (2)
  • Headquarters (2)
  • New Jersey (2)
  • San Francisco (2)
  • Dallas (1)
  • Houston (1)
  • New England (1)
  • New Orleans (1)
  • Seattle (1)
Clear All Results
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

October 04, 2023
NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
October 04, 2023
PRESS RELEASE

Jury Convicts Pain Clinic Doctor of Unlawful Drug Distribution, Money Laundering, and Filing a False Tax Return

June 23, 2023
TAMPA , F la. – United States Attorney Roger B. Handberg announced that a federal jury found Dr. Qing McGaha guilty of 14 counts of unlawful drug distribution, four (4) counts of money laundering, and one (1) count of filing a false tax return. McGaha faces a maximum penalty of...
June 23, 2023
PRESS RELEASE

Former Alaska Advanced Nurse Practitioner Sentenced to 30 Years for Illegally Prescribing Millions of Opioids Causing Five Deaths

June 16, 2023
ANCHORAGE, ALASKA—Former Advanced Nurse Practitioner Jessica Joyce Spayd (52) was sentenced in U.S. District Court yesterday to 30 years (360 months) imprisonment for illegally prescribing and dispensing opioids outside the scope of legitimate medical practice that resulted in the deaths of five people between 2014 and 2019. United States District...
June 16, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

January 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
January 24, 2023
PRESS RELEASE

Northeast Hospital Agrees to Pay $1.9 Million To Resolve Allegations of Controlled Substance Recordkeeping Violations

December 07, 2022
BOSTON – Northeast Hospital Corporation (Northeast), part of Beth Israel Lahey Health, has agreed to pay $1.9 million in civil penalties to resolve allegations that Northeast violated the Controlled Substance Act (the CSA) by failing to keep accurate records of controlled substances, including opioids. The CSA requires accurate inventorying and...
December 07, 2022
PRESS RELEASE

Dentist and TOBAY Worker Charged in 136-Count Indictment for Opioid Prescription Scheme

November 18, 2022
MINEOLA, N.Y. – Nassau County District Attorney Anne T. Donnelly and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III and announced that a Nassau County dentist and a Town of Oyster Bay worker have been indicted for their roles in a scheme to sell opioid prescriptions during...
November 18, 2022
PRESS RELEASE

Pharmacist Admits Filling Counterfeit Prescriptions Selling Oxycodone and Codeine in Exchange for Cash

June 28, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a pharmacist and pharmacy owner pleaded guilty today to violating the Controlled Substances Act by filling fraudulent and counterfeit...
June 28, 2022
PRESS RELEASE

Jury Convicts State Lawmaker of COVID-19 Fraud Scheme at Springfield Health Care Charity

June 28, 2022
SPRINGFIELD, Mo. – A Missouri state representative was convicted by a federal trial jury today for a nearly $900,000 COVID-19 fraud scheme, as well as a separate $200,000 fraud scheme in which she made false claims about a fake stem cell treatment marketed through her clinics in southern Missouri, and...
June 28, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

June 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
June 16, 2022
PRESS RELEASE

North Carolina Pharmacy Agrees to Pay $100,000 Fine

February 03, 2022
DURHAM, N.C. – Aspirar Pharmacy, LLC and Aspirar Pharmacy of Durham, LLC (collectively Aspirar Pharmacy), located in Cary and Durham, North Carolina, respectively, have agreed to pay the United States $100,000 to resolve allegations that they violated the Controlled Substances Act from 2017-2018 by filling prescriptions for a physician who...
February 03, 2022
Showing 11 - 20 of 47 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster